There are indeed many questionable COVID-19 antibody tests currently available in the US market. The FDA recently launched a national investigation of antibody testing manufacturers and is now requiring them to submit clinical testing data and receive an Emergency Use Authorization (EUA). The EUA process requires testing manufacturers to meet the sensitivity and specificity standards established by the FDA to ensure these tests' quality.
ZOOM+Care partners with a national reference lab, LabCorp, to support all of the COVID-19 testing conducted at our clinics. We are continually monitoring this testing platform to ensure our partners meet our rigorous quality standards and the expectations of our patients, clinicians, and the communities we serve.